News
SLGCW
0.0860
0.00%
0.00
Weekly Report: what happened at SLGCW last week (0226-0301)?
Weekly Report · 03/04 10:58
Weekly Report: what happened at SLGCW last week (0219-0223)?
Weekly Report · 02/26 11:09
Weekly Report: what happened at SLGCW last week (0212-0216)?
Weekly Report · 02/19 11:11
Weekly Report: what happened at SLGCW last week (0205-0209)?
Weekly Report · 02/12 11:02
Weekly Report: what happened at SLGCW last week (0129-0202)?
Weekly Report · 02/05 11:09
Weekly Report: what happened at SLGCW last week (0122-0126)?
Weekly Report · 01/29 10:59
Weekly Report: what happened at SLGCW last week (0115-0119)?
Weekly Report · 01/22 11:03
Weekly Report: what happened at SLGCW last week (0108-0112)?
Weekly Report · 01/15 10:59
Weekly Report: what happened at SLGCW last week (0101-0105)?
Weekly Report · 01/08 11:03
Weekly Report: what happened at SLGCW last week (1225-1229)?
Weekly Report · 01/01 10:58
Somalogic Inc: Current report
Press release · 12/29/2023 23:07
Somalogic Inc: Current report
Press release · 12/27/2023 16:13
Weekly Report: what happened at SLGCW last week (1218-1222)?
Weekly Report · 12/25/2023 11:09
Weekly Report: what happened at SLGCW last week (1211-1215)?
Weekly Report · 12/18/2023 11:14
Somalogic Inc: Current report
Press release · 12/13/2023 02:22
Weekly Report: what happened at SLGCW last week (1204-1208)?
Weekly Report · 12/11/2023 11:09
Weekly Report: what happened at SLGCW last week (1127-1201)?
Weekly Report · 12/04/2023 11:09
Weekly Report: what happened at SLGCW last week (1120-1124)?
Weekly Report · 11/27/2023 11:03
More
Webull provides a variety of real-time SLGCW stock news. You can receive the latest news about Somalogic Inc through multiple platforms. This information may help you make smarter investment decisions.
About SLGCW
SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. It offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.